Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Impact of COVID-19 on the Equilibrium of Hereditary Metabolic Disease (MHM) in Patients With or Who Have Contracted COVID-19

NCT04645498 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04645498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04645498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Impact of COVID-19 on the Equilibrium of Hereditary Metabolic Disease (MHM) in Patients With or Who Have Contracted COVID-19
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Withdrawn
Start date
February 1, 2021
Completion date
February 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, metabolism, inborn errors